Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.42B | 11.83B | 9.26B | 7.97B | 7.65B | 5.91B |
Gross Profit | 4.40B | 4.53B | 3.69B | 3.56B | 3.28B | 2.43B |
EBITDA | 1.11B | 1.44B | 1.32B | 1.27B | 1.54B | 822.88M |
Net Income | 390.05M | 341.31M | 350.13M | 399.44M | 550.01M | 107.34M |
Balance Sheet | ||||||
Total Assets | 8.94B | 9.27B | 8.53B | 7.48B | 7.66B | 6.17B |
Cash, Cash Equivalents and Short-Term Investments | 2.92B | 2.52B | 2.54B | 3.31B | 3.89B | 2.86B |
Total Debt | 9.00M | 0.00 | 45.43M | 0.00 | 0.00 | 0.00 |
Total Liabilities | 4.01B | 4.15B | 3.61B | 2.75B | 3.16B | 2.17B |
Stockholders Equity | 4.93B | 5.12B | 4.92B | 4.73B | 4.50B | 4.00B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.35B | -239.89M | -394.04M | 1.14B | -266.27M |
Operating Cash Flow | 0.00 | 1.39B | 876.58M | 910.61M | 1.98B | 555.91M |
Investing Cash Flow | 0.00 | -1.20B | -1.70B | -1.31B | -899.94M | -822.22M |
Financing Cash Flow | 0.00 | -215.24M | -222.35M | -169.65M | -53.25M | -121.44M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥17.95B | 32.69 | 0.17% | 24.15% | -7.80% | ||
76 Outperform | ¥26.86B | 19.92 | 1.94% | 20.63% | 21.52% | ||
76 Outperform | ¥20.52B | 24.42 | 1.77% | 3.71% | -14.56% | ||
65 Neutral | ¥18.53B | 54.49 | 0.92% | 32.25% | 87.20% | ||
65 Neutral | ¥17.67B | 44.92 | ― | 5.32% | -19.27% | ||
59 Neutral | €3.23B | 11.95 | -9.91% | 2.84% | 2.38% | -49.53% | |
¥18.70B | 27.59 | ― | ― | ― |